相似文献
1
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis.
Thorax. 1986 May;41(5):355-9. doi: 10.1136/thx.41.5.355.
2
Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis.
Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):473-4. doi: 10.1164/arrd.1981.123.4.473.
3
Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis.
Am Rev Respir Dis. 1980 Aug;122(2):289-301. doi: 10.1164/arrd.1980.122.2.289.
4
Collagen synthesis and degradation during the development of asbestos-induced pulmonary fibrosis.
Exp Lung Res. 1992 Jan-Mar;18(1):9-20. doi: 10.3109/01902149209020647.
5
Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis.
Clin Sci (Lond). 1986 Jan;70(1):39-45. doi: 10.1042/cs0700039.
6
Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis.
Chest. 1989 Nov;96(5):1115-9. doi: 10.1378/chest.96.5.1115.
7
Increase of biosynthesis and degradation of collagen in normal lungs induced by soluble factors obtained from experimental pulmonary silicosis.
Arch Biol Med Exp. 1987;20(3-4):311-7.
8
[Fibrotic interstitial pneumopathies. Collagenolytic activity of the alveolar fluid].
Presse Med. 1983 May 14;12(21):1345-8.
9
Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis.
Thorax. 1990 Jun;45(6):451-5. doi: 10.1136/thx.45.6.451.
10
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L709-21. doi: 10.1152/ajplung.00418.2012. Epub 2013 Apr 5.
引用本文的文献
1
Serologically assessed markers of fibroblast activity (PRO-C3 and PRO-C6) and risk assessment of pulmonary fibrosis following severe COVID-19 infection.
Eur Clin Respir J. 2025 May 29;12(1):2510032. doi: 10.1080/20018525.2025.2510032. eCollection 2025.
2
TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.
Am J Pathol. 2024 Jul;194(7):1171-1184. doi: 10.1016/j.ajpath.2024.02.021. Epub 2024 Mar 26.
3
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives.
Int J Mol Sci. 2023 Dec 31;25(1):547. doi: 10.3390/ijms25010547.
4
The Preventive Effect of Endostar on Radiation-induced Pulmonary Fibrosis.
Curr Mol Med. 2024;24(5):610-619. doi: 10.2174/1566524023666230406134640.
5
Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics-Model Development and Validation on ARDS and IPF Patients.
IEEE Open J Eng Med Biol. 2021 Jan 22;2:44-54. doi: 10.1109/OJEMB.2021.3053841. eCollection 2021.
6
Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly.
Mol Biol Rep. 2021 Dec;48(12):7775-7785. doi: 10.1007/s11033-021-06790-3. Epub 2021 Oct 13.
7
miR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis.
Nanotoxicology. 2020 Nov;14(9):1175-1197. doi: 10.1080/17435390.2020.1808727. Epub 2020 Sep 14.
8
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.
Respir Res. 2019 Jul 12;20(1):148. doi: 10.1186/s12931-019-1118-7.
9
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis.
Elife. 2018 Jul 3;7:e36354. doi: 10.7554/eLife.36354.
10
Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.
J Cell Biochem. 2015 Nov;116(11):2484-93. doi: 10.1002/jcb.25192.
本文引用的文献
1
Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis.
Am Rev Respir Dis. 1980 Aug;122(2):289-301. doi: 10.1164/arrd.1980.122.2.289.
2
Collagen production rates following acute lung damage induced by butylated hydroxytoluene.
Biochem Pharmacol. 1982 Jun 1;31(11):2053-8. doi: 10.1016/0006-2952(82)90420-8.
3
Changes of collagen content in fibrotic lung disease.
Arch Invest Med (Mex). 1982;13(2):93-100 passim.
4
Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse.
Lab Invest. 1982 Apr;46(4):438-49.
5
Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis.
Hum Pathol. 1980 Jul;11(4):353-66. doi: 10.1016/s0046-8177(80)80031-1.
6
Cell-mediated immunity against connective tissue in experimental pulmonary fibrosis.
Lung. 1982;160(3):131-40. doi: 10.1007/BF02719285.
7
Scleroderma. A model for fibrosis.
Arch Dermatol. 1983 Dec;119(12):957-62. doi: 10.1001/archderm.119.12.957.
8
Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages.
Biochem Biophys Res Commun. 1980 Dec 16;97(3):1108-15. doi: 10.1016/0006-291x(80)91490-4.
9
What controls collagen resorption in vivo?
Med Hypotheses. 1980 Jul;6(7):711-26. doi: 10.1016/0306-9877(80)90089-4.
10
Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen.
Am Rev Respir Dis. 1983 Jul;128(1):82-8. doi: 10.1164/arrd.1983.128.1.82.
Zotero 插件